Vaccination News

Last week, FDA advisors recommended the approval of two respiratory syncytial virus, or RSV, vaccines for older people. It is the first time that RSV vaccines were recommended for approval.

A pediatric infectious disease expert made the case that the world needs a better pertussis vaccine.

An FDA advisory committee recommend the approval of two respiratory syncytial virus vaccines for older people, who are among the most susceptible to severe disease, hospitalization and death from the infection.

Routine HPV vaccination rates could be improved if children were vaccinated earlier, according to a new study.

SEATTLE — In January, Janssen discontinued the phase 3 MOSAICO trial because the HIV vaccine regimen it was testing did not prevent infection — the latest in a string of failed HIV vaccine trials.

During a military deployment to Iraq, a 14-month-old male in a refugee camp presented to sick call (Figure 1) for evaluation of a minor upper respiratory tract infection

Pfizer presented data for the first time publicly Thursday on its maternal vaccine candidate for respiratory syncytial virus, which was granted priority review this week by the FDA.

Preliminary estimates published Thursday in MMWR and presented this week by the CDC indicate that this season’s influenza vaccine offered significant protection among all ages.

SEATTLE — Study findings presented Wednesday at the Conference on Retroviruses and Opportunistic Infections provided more evidence of the effectiveness of vaccines against mpox.

A recent review of randomized controlled trials — most of which were conducted before the COVID-19 pandemic — has become part of the debate on the effectiveness of masks in preventing the spread of respiratory illnesses.